Skip to main content
OpenTrials

Clinical trial condition

Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Explore clinical trials studying Metabolic Dysfunction-Associated Steatohepatitis (MASH). Study availability and eligibility vary by location and protocol.

20 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) trial results

Not Yet Recruiting

Clinical Classification of MAFLD Based Liver Biopsy

NCT06795646

Conditions
Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Xicheng, China
  • Hangzhou Normal University Affiliated Hospital Hangzhou, Xicheng, China
  • Zhongshan Hospital, Fudan University Shanghai, Xicheng, China
  • Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China
View Trial Details
Completed

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT05395481

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
Locations
  • Arizona Liver Health - Chandler Chandler, Arizona, United States
  • Orange County Research Center Orange, California, United States
  • Inland Empire Clinical Trials, LLC Rialto, California, United States
  • Synergy Healthcare LLC Brandon, Florida, United States
View all 16 locations
View Trial Details
Completed

A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

NCT07201831

Conditions
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Locations
  • Novo Nordisk Investigational Site Plainsboro, New Jersey, United States
  • Novo Nordisk Investigational Site Mississauga, Canada
  • Novo Nordisk Investigational Site Puteaux, France
  • Novo Nordisk Investigational Site Mainz, Germany
View Trial Details
Active, Not Recruiting

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

NCT06108219

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • Site #207 Chandler, Arizona, United States
  • Site #209 Tucson, Arizona, United States
  • Site #378 Huntington Park, California, United States
  • Site #439 Lancaster, California, United States
View all 77 locations
View Trial Details

Related conditions